Literature DB >> 22407910

Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT.

Lars Folkestad1, Jannie Dahl Hald, Stinus Hansen, Jeppe Gram, Bente Langdahl, Bo Abrahamsen, Kim Brixen.   

Abstract

Osteogenesis imperfecta (OI) is a hereditary disorder characterized by decreased biosynthesis or impaired morphology of type I collagen that leads to decreased bone mass and increased bone fragility. We hypothesized that patients with OI have altered bone microstructure and bone geometry. In this cross-sectional study we compared patients with type I OI to age- and gender-matched healthy controls. A total of 39 (13 men and 26 women) patients with OI, aged 53 (range, 21-77) years, and 39 controls, aged 53 (range, 21-77) years, were included in the study. Twenty-seven of the patients had been treated with bisphosphonates. High-resolution peripheral quantitative computed tomography (HR-pQCT) at the distal radius and distal tibia and dual-energy X-ray absorptiometry of total hip, femoral neck, trochanteric region, and the lumbar spine (L1-L4) were performed. The patients were shorter than the controls (159 ± 10 cm versus 170 ± 9 cm, p < 0.001), but had similar body weight. In OI, areal bone mineral density (aBMD) was 8% lower at the hip (p < 0.05) and 13% lower at the spine (p < 0.001) compared with controls. The trabecular volumetric bone mineral density (vBMD) was 28% lower in radius (p < 0.001) and 38% lower in tibia (p < 0.001) in OI compared with controls. At radius, total bone area was 5% lower in OI than in controls (p < 0.05). In the tibia, cortical bone area was 18% lower in OI (p < 0.001). In both radius and tibia the number of trabeculae was lower in patients compared to the controls (35% and 38%, respectively, p < 0.001 at both sites). Furthermore, trabecular spacing was 55% higher in OI in both tibia and radius (p < 0.001 at both sites) when compared with controls. We conclude that patients with type I OI have lower aBMD, vBMD, bone area, and trabecular number when compared with healthy age- and gender-matched controls.
Copyright © 2012 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2012        PMID: 22407910     DOI: 10.1002/jbmr.1592

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  16 in total

1.  Finite element analysis of bone strength in osteogenesis imperfecta.

Authors:  Peter Varga; Bettina M Willie; Chris Stephan; Kenneth M Kozloff; Philippe K Zysset
Journal:  Bone       Date:  2020-01-22       Impact factor: 4.398

2.  Classification of micro-CT images using 3D characterization of bone canal patterns in human osteogenesis imperfecta.

Authors:  Anas Z Abidin; John Jameson; Robert Molthen; Axel Wismüller
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03

Review 3.  Bone mass and mineralization in osteogenesis imperfecta.

Authors:  Nadja Fratzl-Zelman; Barbara M Misof; Klaus Klaushofer; Paul Roschger
Journal:  Wien Med Wochenschr       Date:  2015-07-25

Review 4.  Clinical imaging of bone microarchitecture with HR-pQCT.

Authors:  Kyle K Nishiyama; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

5.  Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.

Authors:  J D Hald; L Folkestad; T Harsløf; A M Lund; M Duno; J B Jensen; S Neghabat; K Brixen; B Langdahl
Journal:  Osteoporos Int       Date:  2016-06-02       Impact factor: 4.507

6.  Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.

Authors:  R Kocijan; C Muschitz; J Haschka; D Hans; A Nia; A Geroldinger; M Ardelt; R Wakolbinger; H Resch
Journal:  Osteoporos Int       Date:  2015-05-09       Impact factor: 4.507

Review 7.  Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

Authors:  F S Van Dijk; D O Sillence
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

Review 8.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

9.  Evaluation of teriparatide treatment in adults with osteogenesis imperfecta.

Authors:  Eric S Orwoll; Jay Shapiro; Sandra Veith; Ying Wang; Jodi Lapidus; Chaim Vanek; Jan L Reeder; Tony M Keaveny; David C Lee; Mary A Mullins; Sandesh C S Nagamani; Brendan Lee
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.

Authors:  Catherine L Omosule; Victoria L Gremminger; Ashley M Aguillard; Youngjae Jeong; Emily N Harrelson; Lawrence Miloscio; Jason Mastaitis; Ashique Rafique; Sandra Kleiner; Ferris M Pfeiffer; Anqing Zhang; Laura C Schulz; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2020-12-18       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.